Plattsburgh, N.Y.-based Medisca has issued a voluntary recall of four lots of L-Citrulline after finding these lots do not contain any L-Citrulline.
The U.S. Food and Drug Administration reported receiving several adverse events following the administration of an affected lot "potentially subpotent" L-Citrulline.
L-Citrulline is used to treat urea cycle disorders, and subpotent levels of L-Citrulline can cause potentially life-threatening high levels of ammonia, according to an FDA report.
More Articles on Recalls:
Ben Venue Laboratories Recalls 10% Acetylcysteine Solution
FDA Recalls Covidien's Puritan Bennett 840 Ventilator
FDA Recalls Faulty Antimicrobial Hospital Safety Showers